Biotechnology
BioChek Acquires BIOTECON, Creates Leading Global Player in Veterinary and Food Safety Solutions
REEUWIJK, Netherlands, April 25, 2020 /PRNewswire/ -- BioChek, the specialist company to offer innovative and user-friendly veterinary diagnostic tools, today announced the successful acquisition of BIOTECON, specialised in development and manufacturing of PCR based solutions for food safety dia...
2020-04-25 04:09
2699
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
SEATTLE, April 24, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced it is partnering with AdaptVac to develop and produce a COVID-19 vaccine. AdaptVac, together with its EU Horizon 2020 sponsored PREVENT-nCoV con...
2020-04-24 14:50
3521
Innovent and Eli Lilly Announce NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with ALIMTA® (Pemetrexed) and Platinum as First-Line Therapy in Non-squamous NSCLC
SUZHOU, China, April 24, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jo...
2020-04-24 07:50
7146
Henlius receives EU GMP Certificate for HLX02 (Trastuzumab for Injection)
SHANGHAI, April 23, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the company's drug substance (DS) line and drug product (DP) line for HLX02 trastuzumab biosimilar have successfully passed the European United (EU) Good Manufacturing Practice (GMP) on-site inspectio...
2020-04-23 22:02
3643
Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies
AUSTIN, Texas, April 23, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it is actively developing a COVID-19 triage test aiming to predict the likelihood that an individual who is COVID-19 positive will develop complications and severe disease, usi...
2020-04-23 20:30
6737
MiRXES to mass produce and distribute A*STAR Singapore's tested and proven SARS-CoV-2 RT-PCR test
SINGAPORE, April 23, 2020 /PRNewswire/ -- MiRXES, a homegrown Singapore-based biotech, has received Provisional Authorisation from the Health Sciences Authority (HSA)Singapore, to supply the Fortitude Kit SARS-CoV-2 real-time RT-PCR[1] test. With technology licensed from Singapore's Agency for Sc...
2020-04-23 18:04
3186
Bugworks Raises US$7.5M From a Global Investment Syndicate to Combat the Global Challenge Posed by Deadly Bacterial Superbugs
BANGALORE, India; WILMINGTON, Delaware and ADELAIDE, Australia, April 23, 2020
/PRNewswire/ -- Bugworks Research Inc
2020-04-23 11:30
3165
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody)
SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and ImmuneOncia Therapeutics Inc. announced the successful FDA IND approval of IMC-002 under a development and manufacturing agreement with Samsung Biologics since 2018. As a result, ImmuneOncia will begin Phase 1 ...
2020-04-23 08:00
1470
OncoQuest Announces Signing of a Definitive Agreement to Sell Drug Portfolio to Dual Industrial for U.S. $300 Million and Commitment to Fund the Oregovomab Phase 3 Clinical Trial in Frontline Ovarian Cancer
EDMONTON, Alberta, April 23, 2020 /PRNewswire/ -- OncoQuest Inc., ("OncoQuest" or the "Company") a privately held, cancer immunotherapy company today announced that it has entered into a definitive agreement to sell its clinical and preclinical immunotherapy development assets to Dual Industrial ...
2020-04-23 01:38
8235
Samsung Biologics Earnings to Beat Consensus Again, Continues to Sign New Projects with Enhanced Virtual Support
SONGDO, South Korea, April 22, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced Q1 earnings results onMonday, April 20th. The company posted consolidated sales of207.2 billion Korean Won, operating profit of 62.6 billion Korean Won, and net income of 39.1 billion Korean Won. The ...
2020-04-22 19:00
6140
WuXi Biologics Completed Acquisition of a Drug Product Manufacturing Facility in Germany
SHANGHAI and LEVERKUSEN, Germany, April 22, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition deal with Bayer for a drug product manufacturing plant in Leverkusen,Ge...
2020-04-22 08:00
2251
Seegene's Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
SEOUL, South Korea, April 22, 2020 /PRNewswire/ -- Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 disease. ...
2020-04-22 07:40
2489
FibroGenesis Announces the Filing of its 200th Patent for Fibroblast Cell Therapy Platform
Building on a World Leading Intellectual Property Position with the 200th Patent Filed Today HOUSTON, April 21, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibroblasts (HDFs), today ...
2020-04-21 21:13
1618
Linical and Alpha Cognition Announce Strategic Partnership to Position Alpha-1062 for Approval in the United States and Japan Alzheimer's Markets
STUART, Florida, April 21, 2020 /PRNewswire/ -- Linical Company Limited (Linical) and Alpha Cognition Inc. (ACI) today announced they have signed a partnering agreement whereby Linical will provide strategic consulting services and regulatory guidance for Alpha-1062, a new chemical entity aimed t...
2020-04-21 21:00
2737
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex(TM) Aortic Valve Technology
REHOVOT, Israel, April 21, 2020 /PRNewswire/ -- Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today it has closed a$27 million round of financing, led by Sofinnova Partners, a leading European life scie...
2020-04-21 09:00
2365
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001
SUZHOU and HANGZHOU, China, April 20, 2020 /PRNewswire/ -- Transcenta Holding Limited. ("Transcenta"), a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacturing, today announced that its subsidiary Mabspace Biosciences (Suzhou) Co., Lim...
2020-04-20 23:00
1109
Clarivate Enhances Cortellis Clinical Trials Intelligence with New Site Selection Analytics
Clinical trial planning platform enables researchers to pinpoint best sites to support trial protocols and patient recruitment needs LONDON and PHILADELPHIA, April 20, 2020 /PRNewswire/ -- Clarivate Analytics Plc (NYSE:CCC) a global leader in providing trusted insights and analytics to accelerat...
2020-04-20 17:07
4853
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
SEOUL, South Korea, April 20, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130), a biotechnology company developing innovative therapeutics in immune-oncology, announced today thatthe United States (US) Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) applic...
2020-04-20 14:41
3226
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
SUZHOU, China, April 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 1801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major dis...
2020-04-20 08:00
2291
Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
SUZHOU, China, April 20, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 1801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major dis...
2020-04-20 08:00
8545
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Oxygen, HubSpot's leading solutions partner in Hong Kong & Greater China Expands to UAE
2024-11-15 15:25
8703
How "small apples" march into "big industry" in Yan'an
2024-11-15 17:39
5845
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5183